A phase 2 study of inotuzumab ozogamicin and rituximab, followed by autologous stem cell transplant in patients with relapsed/refractory diffuse large B-cell lymphoma
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Cheolwon Suh Paul Hamlin John Radford Catherine Thieblemont |
| Publication date | February 24, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |